Mindfulness-based interventions linked to weight loss and hormone improvements in women with PCOS

Women assigned to MBI groups showed significant reductions in BMI, body weight, and abdominal circumference compared to controls. Two studies measuring insulin resistance (HOMA-IR) found preliminary improvements in insulin sensitivity. Total testosterone levels and clinical hirsutism both improved significantly in the MBI groups, suggesting effects on reproductive hormone balance. Disease-specific quality of life improved meaningfully, though generic depression and anxiety scores did not show statistically significant differences. The evidence suggests mindfulness-based approaches may act as modulators of metabolism and hormone levels, not solely through stress reduction, though the number of studies examining insulin resistance was small.

The mechanism appears to extend beyond stress relief alone: the meta-analysis suggests MBIs may directly influence metabolic and endocrine pathways. Subgroup patterns showed consistent weight and BMI reductions across the 10 trials, with effect sizes in the small-to-moderate range. Notably, disease-specific quality of life (measured by PCOS-related questionnaires) improved significantly while generic depression and anxiety measures did not, indicating the benefit may be tied to reduced disease burden rather than broad mood elevation. Two studies on insulin resistance showed promise, but this is still limited evidence—more trials directly measuring HOMA-IR would clarify whether improved insulin sensitivity is a primary effect. The testosterone reduction suggests possible effects on ovarian function or metabolic stress responses. Limitations include heterogeneity in intervention types (yoga duration and style varied widely), short follow-up periods in most trials, and absence of long-term outcome data.